
0.1791 Delayed Data As of May 26 | ![]() Today’s Change | 0.15 Today|||52-Week Range 2.77 | -84.82% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Aridis Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +1,016.69% increase from the last price of 0.18.
The current consensus among 1 polled investment analysts is to Buy stock in Aridis Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.